Biotechnology Allogene Therapeutics Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to ALLO-501A for Large B Cell Lymphoma June 8, 2022
Biotechnology CRISPR Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference June 8, 2022
Biotechnology Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference June 8, 2022
Biotechnology FibroGen Announces Completion of Patient Enrollment in LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Duchenne Muscular Dystrophy June 8, 2022
Biotechnology SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Axsome Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 12, 2022 – (NASDAQ: AXSM) June 8, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OSCR, AXSM and ET June 7, 2022
Search
Health
